Αποτελέσματα αναζήτησης - Anne Robinson
- Εμφανίζονται 1 - 20 Αποτελέσματα από 20
-
1
-
2
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp> από Remo Panaccione, J F Colombel, William J. Sandborn, Geert D’Haens, Qian Zhou, P Pollack, Roopal Thakkar, Anne Robinson
Έκδοση 2013Artigo -
3
-
4
Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease από Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams, Sven Mensing, Roopal Thakkar, Anne Robinson, Joel R. Rosh, Frank M. Ruemmele, Walid M. Awni
Έκδοση 2015Artigo -
5
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease από Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel, Anne Robinson, Winnie Lau, Bidan Huang, Paul F. Pollack, Roopal Thakkar, James D. Lewis
Έκδοση 2013Artigo -
6
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease από Stefanie Schreiber, Walter Reinisch, J F Colombel, William J. Sandborn, Daniël W. Hommes, Anne Robinson, B Huang, Kathleen G. Lomax, P Pollack
Έκδοση 2012Artigo -
7
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis από Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Takayuki Matsumoto, Toshifumi Hibi∥, Anne Robinson, Nael M. Mostafa, Jingdong Chao, Vipin Arora, Anne Camez, Roopal Thakkar, Mamoru Watanabe
Έκδοση 2013Artigo -
8
Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona... από J F Colombel, Bindia Jharap, William J. Sandborn, Brian G. Feagan, Laurent Peyrin–Biroulet, Samantha Eichner, Anne Robinson, Nael M. Mostafa, Qian Zhou, Roopal Thakkar
Έκδοση 2016Artigo -
9
One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA... από William J. Sandborn, J F Colombel, Geert D’Haens, Gert Van Assche, Douglas C. Wolf, Martina Kron, A. Lazar, Anne Robinson, Mei Yang, J. Chao, Roopal Thakkar
Έκδοση 2012Revisão -
10
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial από Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, William J. Sandborn, Paul Rutgeerts, Karel Geboes, Joel Petersson, Samantha Eichner, Qian Zhou, Anne Robinson, Holly A. Read, Roopal Thakkar
Έκδοση 2016Artigo -
11
Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohnʼs Disease από William A. Faubion, Marla C. Dubinsky, Frank M. Ruemmele, Johanna C. Escher, Joel R. Rosh, Jeffrey S. Hyams, Samantha Eichner, Yao Li, Nattanan Reilly, Roopal Thakkar, Anne Robinson, Andreas Lazar
Έκδοση 2017Artigo -
12
Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 από Jean–Frédéric Colombel, William J. Sandborn, Subrata Ghosh, Douglas C. Wolf, Remo Panaccione, Brian G. Feagan, Walter Reinisch, Anne Robinson, Andreas Lazar, Martina Kron, Bidan Huang, Martha Skup, Roopal Thakkar
Έκδοση 2014Artigo -
13
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA από Simon Travis, Brian G. Feagan, Laurent Peyrin–Biroulet, Remo Panaccione, Silvio Danese, Andreas Lazar, Anne Robinson, Joel Petersson, Brandee Pappalardo, Mareike Bereswill, Naijun Chen, Song Wang, Martha Skup, Roopal Thakkar, Jingdong Chao
Έκδοση 2017Artigo -
14
Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease από Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shirô Nakamura, Vipin Arora, Anne Robinson, Roopal Thakkar, Toshifumi Hibi∥
Έκδοση 2014Artigo -
15
Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis από Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Laurent Peyrin–Biroulet, Remo Panaccione, P. Rutgeerts, Stephen B. Hanauer, Subrata Ghosh, Gert Van Assche, Anne Robinson, Winnie Lau, J. Maa, B Huang, Brandee Pappalardo, Holly A. Read
Έκδοση 2017Artigo -
16
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results από Geert D’Haens, William J. Sandborn, Edward V. Loftus, Stephen B. Hanauer, Stefan Schreiber, Laurent Peyrin–Biroulet, Remo Panaccione, Julián Panés, Filip Baert, Jean‐Frédéric Colombel, Marc Ferrante, Édouard Louis, Alessandro Armuzzi, Qian Zhou, Venkata Sasikiran Goteti, Nael M. Mostafa, Thao Doan, Joel Petersson, Tricia Finney‐Hayward, Alexandra Song, Anne Robinson, Silvio Danese
Έκδοση 2022Artigo -
17
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial από Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens
Έκδοση 2017Artigo -
18
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study από Brian G. Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert D’Haens, William J. Sandborn, Édouard Louis, Markus F. Neurath, Denis Franchimont, Olivier Dewit, Ursula Seidler, Kyung-Jo Kim, Christian P. Selinger, Steven J. Padula, Ivona Herichova, Anne Robinson, Kori Wallace, Jun Zhao, Mukul Minocha, Mohamed I. A. Othman, Adina Soaita, Sudha Visvanathan, David B. Hall, Wulf O. Böcher
Έκδοση 2018Artigo -
19
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results από Julián Panés, Jean‐Frédéric Colombel, Geert D’Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin–Biroulet, Edward V. Loftus, Silvio Danese, Satoshi Tanida, Yusuke Okuyama, Édouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Toshifumi Hibi∥, Mamoru Watanabe, J Lefèbvre, Tricia Finney‐Hayward, Yuri Sánchez González, Thao Doan, Nael M. Mostafa, Kimitoshi Ikeda, Wangang Xie, Bidan Huang, Joel Petersson, Jasmina Kalabic, Anne Robinson, William J. Sandborn
Έκδοση 2022Artigo -
20
Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes από Marjorie Funk, Kristopher P. Fennie, Kimberly E. Stephens, Jeanine May, Catherine Winkler, Barbara J. Drew, Barbara Borman, Stephanie Calcasola, Mary G. Carey, L. Currie, Leslie L. Davis, Eleanor Fitzpatrick, Rhonda Fleischman, Darice Hawkins, Elise Hazlewood, Rebecca Henry, Cindy Honess, Peggy Kalowes, Sharon Ann Kearns, Bobbi Leeper, Joseph Liggett, Paula Lusardi, Carol Lynn, Manbo Man, Kathleen McCauley, M. Hing, Anita Pang, Janet Parkosewich, JoAnne Phillips, Anne Robinson, Noraliza Salazar, Kristin E. Sandau, Cass Piper Sandoval, Prasama Sangkachand, Rose B. Shaffer, Heather Sherrard, Maureen Smith, Rebecca Stamm, Vickie Strang, Nancy Wen Sim Tee, K. J. Wells, Paula White
Έκδοση 2017Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Medicine
Internal medicine
Disease
Adalimumab
Gastroenterology
Crohn's disease
Ulcerative colitis
Adverse effect
Alternative medicine
Pathology
Placebo
Tumor necrosis factor alpha
Surgery
Chemotherapy
Clinical trial
Environmental health
Maintenance therapy
Physics
Population
Inflammatory bowel disease
Intensive care medicine
Randomized controlled trial
Clinical endpoint
Combination therapy
Dermatology
Discontinuation
Dosing
Family medicine
Immunology
Incidence (geometry)